Navalign »

Mineralys Therapeutics shares owned by Navalign

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Navalign from 13F filings

Historical chart of Navalign investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Navalign consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Navalign

Quarter filed Position value Share count Share price at filing
2025-12-31 $33k 900 36.29

More positions owned by Navalign

Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Apple (AAPL)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Ishares Tr Core S&p Scp Etf (IJR)
Spdr Series Trust State Street Spd (SPYV)
Spdr Series Trust State Street Spd (SPYG)
Schwab Strategic Tr Us Tips Etf (SCHP)
Flexshares Tr Mornstar Upstr (GUNR)
First Tr Exchng Traded Fd Vi Smith Unconstrai (UCON)
Vanguard Index Fds Real Estate Etf (VNQ)
Ishares Tr Calif Mun Bd Etf (CMF)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)

View all positions for Navalign

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Citadel Advisors
FMR
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management

View all funds holding Mineralys Therapeutics